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Abstract
AIM: This research aim to know the comparison of efficacy of the effect therapy uses generic ciprofloxacin and 
branded drug tequinol from patient of typhoid fever.
METHODS: The research method has the character of the descriptive observational with the technique intake of 
sample is consecutive sampling/quota sampling. Subject research was conducted on 67 sample fulfilling criterion of 
inclusion and exclusion diagnosed by typhoid fever at period January–March 2018.
RESULTS: Thirty-four patients use the generic ciprofloxacin and 33 patients use the brand tequinol. Time of fever 
degradation for patient using brand tequinol range from 1 to 3 day and for patient using generic ciprofloxacin 3–7 day.
CONCLUSION: After tested to use the Mann–Whitney test, there is difference having a meaning of hospitalization 
of to lodge briefer and free from fever quicker at brand tequinol than generic ciprofloxacin at patient of typhoid fever 
in RSUD Haji Makassar (p < 0.05).
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Introduction
Based on observations made in December 
2017 at the Haji District Hospital in South Sulawesi 
Province, it is one of the public hospitals that offers 
modern, complete, and quality Islamic health services 
for children, individuals, families, and employees of 
all age groups so that the hospital this is often used 
by the community as a place of treatment, especially 
for patients suffering from typhoid fever. Haji Regional 
Hospital of South Sulawesi Province is one of the 
hospitals that handle the most typhoid fever by ranking 
first in 2016 in South Sulawesi based on the disease 
index data in the Haji Regional Hospital of South 
Sulawesi Province.
From the results of observations of data on 
the use of drugs for typhoid fever in Haji Hospital 
South Sulawesi Province, the use of generic drugs 
during January 2018–March 2018 was 62.25% and 
branded drugs were 37.77%. Based on observations, 
the cure for typhoid fever using the ciprofloxacin 
generic drug with a drug uses rate of 17.65% and 
tequinol brand of 16.66% of a total of 204 cases. 
Typhoid fever is a systemic infection caused by 
Salmonella enterica serovar Typhi (Salmonella typhi) 
[1]. Therapy that can be done to treat diseases 
caused by bacterial infections such as S. typhi is by 
giving the right antibiotics. Based on antibiotic use 
data at the Makassar Hajj District General Hospital, 
the antibiotic that is often prescribed for S. typhi 
bacterial infections that cause typhoid fever is the 
drug ciprofloxacin [2].
The choice of antibiotic for S. typhi infection 
depends on the severity of the infection. The primary 
choice of infection pharmacotherapy in S. typhi bacteria 
according to Pharmacotherapy A Pathophysiologic 
Approach Edition 10 of 2017 is ciprofloxacin, 
levofloxacin, ceftriaxone, and cefotaxime [3].
Previous research by Kesselheim et al., [4] in 
the journal Clinical Equivalence of Generic and Brand-
name Drugs used in Cardiovascular Disease believes 
that generic drugs and branded drugs have almost the 
same bioequivalent and equally worthy drug choices. 
For all patients by Karan et al. [5], whereas according 
to Tange et al. [6] that generic drugs and branded drugs 
have a large difference in the level of impurity (impurity) 
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of about 3% in the formulation so that it affects the 
bioavailability of the drug.
Based on observations at Makassar Haji 
Hospital, doctors often prescribe generic drugs to 
patients but not a few also prescribe branded drugs. 
This is because doctors are usually faced with the 
constraints of generic drug stock vacancies so that 
doctors eventually turn to trademarked drugs or patent 
medicines. As a result, the use of branded drugs is 
increasingly being prescribed by doctors to patients 
especially if the patient comes for treatment a second 
time it will be given a similar prescription for the same 
case before.
Materials and Methods
Data collection
A total of 67 cases of a total of 204 cases that 
met the inclusion and exclusion criteria diagnosed 
with typhoid fever in the January 2018–March 2018 
period were then sampled to compare the therapeutic 
results of the use of 34 patients using the generic drug 
ciprofloxacin and 33 patients using brand tequinol.
Data analysis
Data were then analyzed with the help 
of descriptive statistical methods using the SPSS 
application version 24. Patient demographic profiles for 
each area of therapy were expressed in terms of gender 
(number and percentage), and age class (number and 
percentage), type of drug used, outcome of patient 
treatment outcomes, and duration of therapy seen from 
the disappearance of fever.
The criteria for patients in this study are as 
follows:
Inclusion Criteria
The following criteria were included in the 
study:
a. Adult patients (15–60 years) with a diagnosis 
of typhoid fever who have been hospitalized 
during January-2018
b. Patients treated with positive Widal test results
c. Patients receiving ciprofloxacin generic 
antibiotic treatment
d. Patients receiving antibiotic treatment with 
brand name tequinol
e. Patients who do not have concomitant diseases
f. Patients who are otherwise allowed to go 
home/recover by a doctor.
Exclusion criteria
The following criteria were excluded from the study:
a. Typhoid fever patients with concomitant diseases
b. Patient did not complete therapy/forced discharge
c. Patients with incomplete and unclear medical 
records.
Research parameters
a. Duration of patient’s fever decreased days 
(fever free time)
b. The patient’s length of stay.
Results
Based on Table 1 can be seen ciprofloxacin 
generic frequency data 34 or 50.7% and cumulative 
percent of 50.7%. Meanwhile, the frequency of brand 
tequinol is 33 or 49.3%.
Table 1: Distribution of inpatient antibiotic use for typhoid 
fever in Makassar Haji Hospital
Antibiotic Frequency (%)
GC 34 50.7
BT 33 49.3
Total 67 100.0
The length of stay of typhoid fever patients 
while in Makassar Hajj General Hospital with the longest 
stay for 8 days with a total of 1 patient (1.5%) and the 
most frequent length of stay, namely, during 4 days with 
a total of 26 patients (38.8%) (Table 2).
There were 17 patients who used the tequinol 
brand who experienced a decrease in fever within 
3 days and 11 patients using the generic ciprofloxacin. 
The day of fever reduction which has the most frequency 
in patients using Ciprofloxacin is 4 days with a total of 
16 patients (Table 3).
Based on the Mann–Whitney statistical test, 
the value obtained is 85,000 and the significance value 
is 0.000 or (p < 0.05) by Sopiyudin [7], because p < 0.05 
can be concluded that “there is a significant difference 
between the generic use of ciprofloxacin and the tequinol 
brand against length of stay of the patient” (Table 4).
Discussion
Based on the results of the study, the distribution 
of the number of typhoid fever patients by sex is male 
(37.3%) and female (62.7%). Typhoid fever can occur in 
all sexes in both women and men. This is in accordance 
with the report of the Ministry of Health of the Republic 
of Indonesia Ministry of Health [8] that typhoid fever is 
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found more in women than men. Symptoms of typhoid 
fever usually appear 1–3 weeks after exposure and 
may be mild or severe. Symptoms based on research 
conducted most commonly experienced by typhoid 
fever patients are fever/heat as much as 100% or a 
total of 67 patients. Symptoms in the form of fever are 
the most prominent symptom. Fever will be followed 
by other non-typical symptoms such as diarrhea, 
constipation, anorexia, nausea, and vomiting [9].
Table 3: Disturbances for the length of day of fever reduction in 
typhoid fever patients based on the type of antibiotic
Count
Kind antibiotic Day of fever reduction (day)’ Total patient
1 2 3 4 5 7
GC 0 0 11 16 6 1 34
BT 1 15 17 0 0 0 33
Total patient 1 15 28 16 6 1 67
Patients who were said to have typhoid fever 
were patients who had Widal values >1/160–>1/640 for 
agglutinin O and H with single or combined diagnostic 
criteria by Jawetz et al. [10], Widal test is a laboratory 
examination to detect the presence or absence of 
antibodies in patients with antigens O (from the body 
of germs), H antigens (germ flagella), and Vi antigens 
germ capsules [11]. In this study, the antibiotics used 
were generic ciprofloxacin and brand tequinol. Both 
types of antibiotics have the same active ingredient, 
namely, ciprofloxacin. Ciprofloxacin drug is one of the 
fluoroquinolone antibiotics. According to Bueno and 
Stull [12], fluoroquinolone is an antibiotic that has a 
broad spectrum and has strong activity in inhibiting 
Gram-positive and Gram-negative bacteria.
Table 4: Statistical results of Mann–Whitney description of length 
of stay and length of fever reduction in typhoid fever patients at 
Makassar Haji Hospital in the period January-March 2018
Parameter LRI LPD
Mann–Whitney U 85.000 142.500
Wilcoxon W 646.000 703.500
Z −6.244 −5.529
Asymp. Sig. (2-tailed) 0.000 0.000
The fastest average length of treatment was 
patients who received therapy with brand tequinol than 
patients who received the ciprofloxacin generic and 
after being tested using the Mann–Whitney statistical 
test obtained a significance value of 0.000 or (p < 0.05) 
because p < 0.05, Sopiyudin [7] can be concluded that 
“there is a significant difference between the generic 
use of ciprofloxacin and the tequinol brand on the length 
of stay of patients.”
The therapeutic response seen from the heat-
free time is one of the parameters of the success of 
the treatment of typhoid fever; if the body temperature 
drops it means the treatment is successful, whereas 
if the temperature remains high there may be other 
infections, complications, or multidrug resistant 
S. typhi. The antibiotic that gives the fastest fever-free 
time is the tequinol brand compared to the ciprofloxacin 
generic. The duration of fever reduction for patients 
using the tequinol brand ranges from 1 to 3 days and for 
patients using ciprofloxacin generic ranges 3–7 days. 
The length of time the patient’s fever is reduced which 
is also influenced by the symptoms the patient has. 
After being tested using the Mann–Whitney test, there 
was a significant difference in fever-free time between 
generic ciprofloxacin and tequinol brand in typhoid fever 
patients in Makassar Haji Hospital (p < 0.05).
The Spearman correlation value between 
length of stay with the type of antibiotic (generic 
ciprofloxacin and brand tequinol) was −0.769 and the 
Spearman correlation value between the duration 
of fever reduction with the type of antibiotic (generic 
ciprofloxacin and brand tequinol) was −0.681 indicating 
that the direction of the negative correlation with 
the strength of the correlation was strong (0.769; 
0.681 > 0.5) [13].
Conclusion
The therapeutic effect of using brand tequinol 
gives shorter stay than ciprofloxacin. The therapeutic 
effect of using brand tequinol gives a time to reduce 
fever faster than generic ciprofloxacin.
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